{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T08:57:47Z","timestamp":1648889867446},"reference-count":7,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1001\/jamadermatol.2018.4847","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T20:35:53Z","timestamp":1547066153000},"page":"147","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic Criteria and Phenotypes of Pemphigoid and the Association With Gliptins"],"prefix":"10.1001","volume":"155","author":[{"given":"Asli Bilgic","family":"Temel","sequence":"first","affiliation":[{"name":"Department of Dermatology, St George Hospital, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dedee F.","family":"Murrell","sequence":"additional","affiliation":[{"name":"Department of Dermatology, St George Hospital, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"key":"ded180025r1","article-title":"Assessment of diagnostic strategy for early recognition of bullous and nonbullous variants of pemphigoid","author":"Meijer","journal-title":"JAMA Dermatol"},{"key":"ded180025r2","article-title":"Assessment of the prevalence of mucosal involvement in bullous pemphigoid","author":"Kridin","journal-title":"JAMA Dermatol"},{"key":"ded180025r3","article-title":"Association of dipeptidyl peptidase 4 inhibitor use with risk of bullous pemphigoid in patients with diabetes","author":"Lee","journal-title":"JAMA Dermatol"},{"issue":"1","key":"ded180025r4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0190-9622(92)70161-8","article-title":"Immunofluorescence on split skin for the detection and differentiation of basement membrane zone autoantibodies.","volume":"27","author":"Gammon","year":"1992","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"ded180025r5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2340\/00015555-2473","article-title":"The reliability, validity and responsiveness of two disease scores (BPDAI and ABSIS) for bullous pemphigoid: which one to use?","volume":"97","author":"Wijayanti","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"ded180025r6","article-title":"Evaluation of ear, nose and throat involvement in pemphigus vulgaris in comparison with pemphigus severity scoring systems: a cross-sectional study.","author":"Bilgic-Temel","journal-title":"Acta Dermatovenerol Croat"},{"issue":"6","key":"ded180025r7","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.jaad.2018.05.030","article-title":"Oral diabetes medications other than dipeptidyl peptidase 4 inhibitors are not associated with bullous pemphigoid: a Finnish nationwide case-control study.","volume":"79","author":"Varpuluoma","year":"2018","journal-title":"J Am Acad Dermatol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2719746","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T23:51:10Z","timestamp":1550101870000},"score":1,"resource":{"primary":{"URL":"http:\/\/archderm.jamanetwork.com\/article.aspx?doi=10.1001\/jamadermatol.2018.4847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2018.4847","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2,1]]}}}